Breaking News Instant updates and real-time market news.

ARES

Ares Management

$22.70

-0.35 (-1.52%)

06:17
02/15/18
02/15
06:17
02/15/18
06:17

Ares Management initiates payment of quarterly dividend

Ares elected to change its tax classification from a partnership to a C-Corporation to be effective March 1. COO and CFO Michael McFerran stated, "In concurrence with this change, Ares will begin paying a steady, quarterly dividend for each calendar year based on the growth in our after-tax core fee related earnings. This dividend policy should reduce the historical volatility of our distributions, and allow us to retain a greater portion of our earnings for growth and potential share repurchases." Ares declared a distribution of 40c per common unit for the five months ended February 28, inclusive of 25c per common unit for 4Q17 and 15c per common unit for the first two months of 1Q18, payable on February 28 to common unitholders of record at the close of business on February 26. The distribution represents a portion of the estimated after tax distributable earnings generated for the five month period ended February 28. For March 2018, the first month that Ares is taxed as a corporation, Ares declared a dividend of 9.33c per common share payable on April 30 to holders of record on April 16. Ares declared a distribution of 43.75c per Series A Preferred Unit with a payment date of March 31 to preferred unitholders of record as of the close of business on March 15.

  • 15

    Feb

  • 06

    Mar

ARES Ares Management
$22.70

-0.35 (-1.52%)

05/11/17
05/11/17
UPGRADE
Target $23

Outperform
Ares Management upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Craig Siegenthaler upgraded Ares Management to Outperform from Neutral, with a $23 price target, given recent underperformance in the stock. The analyst says "strong" growth prospects given lower capacity constraints across its business, management fee rich profit stream, and high insider ownership that has never sold stock has him positive on the business.
06/29/17
RBCM
06/29/17
INITIATION
Target $21
RBCM
Outperform
Ares Management initiated with an Outperform at RBC Capital
RBC Capital analyst Kenneth Lee started Ares Management with an Outperform rating and $21 price target.
01/10/18
FBCO
01/10/18
NO CHANGE
Target $33
FBCO
Outperform
Ares Management price target raised to $33 from $25 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for Ares Management to $33 from $25 as he believes the macro backdrop should provide tailwinds for the Alternative Asset Managers while lower corporate tax rate should boost the valuation of their underlying portfolios. The analyst reiterates an Outperform rating on the shares.
01/30/18
MSCO
01/30/18
NO CHANGE
MSCO
Morgan Stanley says Ares may be first, Apollo may gain most from C-corp convert
Morgan Stanley analyst Michael Cyprys said he sees an opportunity for Alternative Asset Managers to unlock value by converting to C-corps, as shifting from a partnership structure could help alleviate some tax reporting complexities and expand the universe of eligible investors. He sees Ares Management (ARES) as possibly the first to convert and expects a potential announcement or indications of management's intentions about a conversion when the company reports earnings on February 15. While Ares may be first, Cyprys sees Apollo Global (APO) as potentially being able to unlock the most value from a conversion, with 26% near-term upside possible if the shares re-rate. He sees a less favorable conversion scenario for asset managers with lower taxes and/or greater exposure to performance fees, including KKR (KKR), Carlyle Group (CG) and Blackstone (BX), Cyprys tells investors.

TODAY'S FREE FLY STORIES

XLE

Energy Select Sector SPDR

$59.53

-1.4 (-2.30%)

15:50
12/18/18
12/18
15:50
12/18/18
15:50
Options
Defensive option play in SPDR Energy Fund as shares falter to 52-week lows »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$53.87

-0.35 (-0.65%)

15:47
12/18/18
12/18
15:47
12/18/18
15:47
Periodicals
Citi may take nearly $180M loss on loans to Asian hedge fund, Bloomberg says »

Citigroup could face…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 11

    Feb

  • 15

    Apr

  • 13

    Jul

IGT

International Game

$16.17

0.57 (3.65%)

15:45
12/18/18
12/18
15:45
12/18/18
15:45
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

AXGN

AxoGen

$20.38

-7.15 (-25.97%)

15:44
12/18/18
12/18
15:44
12/18/18
15:44
Hot Stocks
Cliffside says Seeking Alpha's AxoGen story doesn't meet editorial standards »

Cliffside Research said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$48.43

-0.35 (-0.72%)

, FOXA

21st Century Fox

$48.74

-0.26 (-0.53%)

15:42
12/18/18
12/18
15:42
12/18/18
15:42
Periodicals
Advertisers pull out of Tucker Carlson's show after immigrant remarks, AP says »

Certain advertisers are…

FOX

21st Century Fox

$48.43

-0.35 (-0.72%)

FOXA

21st Century Fox

$48.74

-0.26 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$0.00

(0.00%)

15:42
12/18/18
12/18
15:42
12/18/18
15:42
Periodicals
Uber asks for Chinese tariff exclusion amid e-bike ramp, Bloomberg says »

Ride-hailing giant Uber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$68.88

-1.79 (-2.53%)

, AET

Aetna

$0.00

(0.00%)

15:36
12/18/18
12/18
15:36
12/18/18
15:36
Periodicals
Judge defers ruling on keeping CVS, Aetna separate, Bloomberg reports »

U.S. District Judge…

CVS

CVS Health

$68.88

-1.79 (-2.53%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SCS

Steelcase

$14.21

0.04 (0.28%)

15:34
12/18/18
12/18
15:34
12/18/18
15:34
Options
Steelcase options imply 15.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

GD

General Dynamics

$162.31

-1.12 (-0.69%)

15:32
12/18/18
12/18
15:32
12/18/18
15:32
Hot Stocks
General Dynamics announces awarded of $335M U.S. Army contract »

The U.S. Army has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

15:30
12/18/18
12/18
15:30
12/18/18
15:30
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

BIIB

Biogen

$291.73

-21.49 (-6.86%)

, MYL

Mylan

$28.72

-0.13 (-0.45%)

15:29
12/18/18
12/18
15:29
12/18/18
15:29
On The Fly
Street Fight: Analysts differ on Biogen as Tecfidera concerns send shares lower »

Shares of Biogen (BIIB)…

BIIB

Biogen

$291.73

-21.49 (-6.86%)

MYL

Mylan

$28.72

-0.13 (-0.45%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 18

    Mar

TACT

Transact Technologies

$8.46

-0.22 (-2.53%)

15:26
12/18/18
12/18
15:26
12/18/18
15:26
Hot Stocks
Grand Slam reports 7% stake in Transact, sends letter to board »

The letter said in part :…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:25
12/18/18
12/18
15:25
12/18/18
15:25
Conference/Events
Guggenheim CIO fixed income to hold an analyst/industry conference call »

Chief Investment…

AMC

AMC Entertainment

$13.89

-0.17 (-1.21%)

15:22
12/18/18
12/18
15:22
12/18/18
15:22
Conference/Events
AMC Entertainment management to meet with Wedbush »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

PFE

Pfizer

$42.14

-0.97 (-2.25%)

15:20
12/18/18
12/18
15:20
12/18/18
15:20
Options
Upside call buyers in Pfizer weekly contracts »

Upside call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 05

    Jan

  • 29

    Jan

JBL

Jabil

$22.08

0.52 (2.41%)

15:19
12/18/18
12/18
15:19
12/18/18
15:19
Options
Jabil Circuit options imply 11.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/18/18
12/18
15:17
12/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/18/18
12/18
15:16
12/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:12
12/18/18
12/18
15:12
12/18/18
15:12
Conference/Events
Morgan Stanley REITs analyst to hold an analyst/industry conference call »

REITs Analyst Vikram Hill…

CLGX

CoreLogic

$35.67

0.08 (0.22%)

15:07
12/18/18
12/18
15:07
12/18/18
15:07
Hot Stocks
CoreLogic acquires incurance claim solutions firm Symbility Solutions »

Symbility Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$270.49

7.61 (2.89%)

15:06
12/18/18
12/18
15:06
12/18/18
15:06
Periodicals
Netflix testing $3-per-week subscription plan in Europe, BGR reports »

Netflix users in Austria…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$254.76

-0.36 (-0.14%)

, SPX

S&P 500

$0.00

(0.00%)

15:05
12/18/18
12/18
15:05
12/18/18
15:05
Periodicals
Schumer says Dems would 'seriously consider' stopgap funding, Bloomberg says »

Bloomberg cites Chuck…

SPY

SPDR S&P 500 ETF Trust

$254.76

-0.36 (-0.14%)

SPX

S&P 500

$0.00

(0.00%)

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
12/18/18
12/18
15:05
12/18/18
15:05
General news
FOMC widely expected to hike rates Wednesday »

FOMC widely expected to…

FDX

FedEx

$184.17

1.97 (1.08%)

15:04
12/18/18
12/18
15:04
12/18/18
15:04
Options
Fedex options imply 9.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

QCOM

Qualcomm

$57.95

0.96 (1.68%)

, AAPL

Apple

$165.48

1.43 (0.87%)

14:59
12/18/18
12/18
14:59
12/18/18
14:59
Periodicals
Qualcomm seeks to extend ban in China to new Apple iPhones, Bloomberg says »

Qualcomm's (QCOM)…

QCOM

Qualcomm

$57.95

0.96 (1.68%)

AAPL

Apple

$165.48

1.43 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.